These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25708926)

  • 1. Duration of anticoagulation after venous thromboembolism in real world clinical practice.
    Ageno W; Samperiz A; Caballero R; Dentali F; Di Micco P; Prandoni P; Becattini C; Uresandi F; Verhamme P; Monreal M;
    Thromb Res; 2015 Apr; 135(4):666-72. PubMed ID: 25708926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
    Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
    Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
    Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimal duration of anticoagulation of venous thromboembolism].
    Savina EN; Couturaud F
    J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.
    Gussoni G; Frasson S; La Regina M; Di Micco P; Monreal M;
    Thromb Res; 2013 Jan; 131(1):24-30. PubMed ID: 23141849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.
    Nieto JA; Camara T; Gonzalez-Higueras E; Ruiz-Gimenez N; Guijarro R; Marchena PJ; Monreal M;
    Thromb Haemost; 2008 Nov; 100(5):789-96. PubMed ID: 18989522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.
    Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C
    Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
    Blanco-Molina Á; Trujillo-Santos J; Pesavento R; Rosa V; Falgá C; Tolosa C; Mazzolai L; Sampériz Á; Duce R; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S6-S10. PubMed ID: 28262237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation Therapy for Venous Thromboembolism in the Real World　- From the COMMAND VTE Registry.
    Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Konishi T; Akao M; Kobayashi Y; Inoue T; Oi M; Izumi T; Takahashi K; Tada T; Chen PM; Murata K; Tsuyuki Y; Sakai H; Saga S; Sasa T; Sakamoto J; Yamada C; Kinoshita M; Togi K; Ikeda T; Ishii K; Kaneda K; Mabuchi H; Otani H; Takabayashi K; Takahashi M; Shiomi H; Makiyama T; Ono K; Kimura T;
    Circ J; 2018 Apr; 82(5):1262-1270. PubMed ID: 29576597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B blood group: A strong risk factor for venous thromboembolism recurrence.
    Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
    Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism in nonagenarians. Findings from the RIETE Registry.
    Vasco B; Villalba JC; Lopez-Jimenez L; Falga C; Montes J; Trujillo-Santos J; Monreal M;
    Thromb Haemost; 2009 Jun; 101(6):1112-8. PubMed ID: 19492156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.
    de Jong PG; Coppens M; Middeldorp S
    Br J Haematol; 2012 Aug; 158(4):433-41. PubMed ID: 22734929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
    Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
    Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term treatment of venous thromboembolism].
    Meyer G; Couturaud F
    Rev Prat; 2015 Feb; 65(2):208-13. PubMed ID: 25939225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimum duration of anticoagulant treatment after an episode of venous thromboembolism].
    Couturaud F; Kearon C
    Rev Pneumol Clin; 2008 Dec; 64(6):305-15. PubMed ID: 19084210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registry.
    Cote LP; Greenberg S; Caprini JA; Stone J; Arcelus JI; López-Jiménez L; Rosa V; Schellong S; Monreal M;
    Clin Appl Thromb Hemost; 2014 Nov; 20(8):772-8. PubMed ID: 24798686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.